No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2254194 |
chr20:1549402-1549403 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs188421681 |
chr20:1549426-1549427 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs79699278 |
chr20:1549548-1549549 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs374895236 |
chr20:1549550-1549551 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs572512524 |
chr20:1549640-1549641 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs530653326 |
chr20:1549642-1549643 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs3848789 |
chr20:1549654-1549655 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs556088320 |
chr20:1549659-1549660 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs564348978 |
chr20:1549701-1549702 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs528337937 |
chr20:1549758-1549759 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs546891710 |
chr20:1549790-1549791 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs370190191 |
chr20:1549807-1549808 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs561896751 |
chr20:1549820-1549821 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs529232065 |
chr20:1549821-1549822 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs112885875 |
chr20:1549836-1549837 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs113460623 |
chr20:1549936-1549937 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs192252316 |
chr20:1550047-1550048 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs373053185 |
chr20:1550119-1550120 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs567058012 |
chr20:1550140-1550141 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs147963521 |
chr20:1550199-1550200 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs114332427 |
chr20:1550216-1550217 |
Enhancers Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs574287248 |
chr20:1550240-1550241 |
Enhancers Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs149001455 |
chr20:1550241-1550242 |
Enhancers Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs557044535 |
chr20:1550268-1550269 |
Enhancers Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs183892729 |
chr20:1550298-1550299 |
Enhancers Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs545925986 |
chr20:1550319-1550320 |
Enhancers Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs16995310 |
chr20:1550334-1550335 |
Enhancers Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs573007532 |
chr20:1550350-1550351 |
Enhancers Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs115257995 |
chr20:1550359-1550360 |
Enhancers Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs188359364 |
chr20:1550396-1550397 |
Enhancers Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs181810686 |
chr20:1550406-1550407 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs560379688 |
chr20:1550422-1550423 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs550550874 |
chr20:1550458-1550459 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs143783305 |
chr20:1550482-1550483 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs148137938 |
chr20:1550483-1550484 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs551873746 |
chr20:1550510-1550511 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs115996034 |
chr20:1550541-1550542 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs368037437 |
chr20:1550574-1550575 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs577031258 |
chr20:1550585-1550586 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs549341292 |
chr20:1550594-1550595 |
Enhancers Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs567959012 |
chr20:1550674-1550675 |
Enhancers Genic enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs141015957 |
chr20:1550690-1550691 |
Enhancers Genic enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs556959123 |
chr20:1550728-1550729 |
Enhancers Genic enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs145055610 |
chr20:1550762-1550763 |
Enhancers Genic enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs114460475 |
chr20:1550802-1550803 |
Enhancers Genic enhancers Strong transcription Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs115550343 |
chr20:1550832-1550833 |
Enhancers Genic enhancers Strong transcription Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs545946549 |
chr20:1550854-1550855 |
Enhancers Genic enhancers Strong transcription Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs373738755 |
chr20:1550881-1550882 |
Enhancers Genic enhancers Strong transcription Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs540418132 |
chr20:1550891-1550892 |
Enhancers Genic enhancers Strong transcription Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs561773014 |
chr20:1550931-1550932 |
Enhancers Genic enhancers Strong transcription Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|